| 1 |
Present and Future of Surface-Enhanced Raman Scattering
Judith Langer et al. · ACS Nano
Open access |
3 Sep 2019 |
3,910 |
| 2 |
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Yu Shi et al. · Nature
Open access |
17 Apr 2019 |
437 |
| 3 |
Measurement of single-cell dynamics
David G. Spiller, Christopher D. Wood, David A. J. Rand et al. · Nature
|
Jun 2010 |
415 |
| 4 |
De novo design of a fluorescence-activating β-barrel
Jiayi Dou, Anastassia Andreevna Vorobieva, William Sheffler et al. · Nature
Open access |
11 Sep 2018 |
390 |
| 5 |
Uniform nomenclature for the mitochondrial contact site and cristae organizing system
Nikolaus Pfanner et al. · The Journal of Cell Biology
Open access |
31 Mar 2014 |
262 |
| 6 |
Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy
Shanshan Qi, Jia-Hui Sun, Hao-Han Yu et al. · Drug Delivery
Open access |
2017 |
217 |
| 7 |
Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma
Sophia Gayle, Sean F. Landrette, Neil Beeharry et al. · Blood
Open access |
20 Jan 2017 |
214 |
| 8 |
LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
Sau-Chi Betty Yan et al. · Investigational New Drugs
Open access |
27 Dec 2012 |
165 |
| 9 |
Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit
Hartmut Koeppen et al. · Clinical Cancer Research
Open access |
Apr 2014 |
137 |
| 10 |
Label-free mass spectrometry-based protein quantification technologies in proteomic analysis
Mu Wang, Jingjing You, Kerry G. Bemis et al. · Briefings in Functional Genomics and Proteomics
Open access |
25 Jun 2008 |
132 |
| 11 |
Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity
Robert M. Campbell et al. · Molecular Cancer Therapeutics
|
19 Dec 2013 |
124 |
| 12 |
Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma
Binghua Li et al. · Hepatology
Open access |
4 Aug 2023 |
106 |
| 13 |
A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
Lianhai Zhang, Jie Yang, Jie Cai et al. · Scientific Reports
Open access |
21 Oct 2013 |
87 |
| 14 |
Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment
Ying Jin, Xiaoyu An, Binchen Mao et al. · Scientific Reports
Open access |
28 Feb 2022 |
74 |
| 15 |
Compensatory ion transport buffers daily protein rhythms to regulate osmotic balance and cellular physiology
Alessandra Stangherlin et al. · Nature Communications
Open access |
15 Oct 2021 |
67 |
| 16 |
Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates
Leigh Goedeke, Liang Peng, Valle Montalvo-Romeral et al. · Science Translational Medicine
Open access |
2 Oct 2019 |
67 |
| 17 |
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors
Dennis Plenker et al. · Science Translational Medicine
Open access |
14 Jun 2017 |
65 |
| 18 |
Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)
Guodong Zhang, Xiaoli Wang, Tzu-Yang Chung et al. · BMC Gastroenterology
Open access |
15 Oct 2020 |
64 |
| 19 |
nmrML: A Community Supported Open Data Standard for the Description, Storage, and Exchange of NMR Data
Daniel Schober et al. · Analytical Chemistry
Open access |
16 Oct 2017 |
63 |
| 20 |
The design, analysis and application of mouse clinical trials in oncology drug development
Sheng Jie Guo, Xiaoqian Jiang, Binchen Mao et al. · BMC Cancer
Open access |
22 Jul 2019 |
62 |
| 21 |
Experimental animal modeling for immuno-oncology
Qi‐Xiang Li, Gerold Feuer, Xuesong Ouyang et al. · Pharmacology & Therapeutics
|
4 Feb 2017 |
62 |
| 22 |
Raman Spectroscopy to Monitor Post-Translational Modifications and Degradation in Monoclonal Antibody Therapeutics
Bethan S. McAvan, Leo A. Bowsher, Thomas Powell et al. · Analytical Chemistry
Open access |
2 Jul 2020 |
61 |
| 23 |
Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine
Lauren Nicole Bell, Lydia S.H. Lee, Romil Saxena et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology
Open access |
19 Feb 2010 |
59 |
| 24 |
Biogeography and Virulence of Staphylococcus aureus
Juan Fan, Min Shu, Ge Zhang et al. · PLoS ONE
Open access |
10 Jul 2009 |
57 |
| 25 |
Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer
Louise A. Koopman, Mikkel G. Terp, Gijs G. Zom et al. · JCI Insight
Open access |
10 Oct 2019 |
56 |
| 26 |
Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines
Sheng Jie Guo, Wubin Qian, Jie Cai et al. · Cancer Research
|
21 Jun 2016 |
56 |
| 27 |
NSCLC harboring EGFR exon‐20 insertions after the regulatory C ‐helix of kinase domain responds poorly to known EGFR inhibitors
Mengmeng Yang, Xiaoxi Xu, Jie Cai et al. · International Journal of Cancer
|
18 Feb 2016 |
56 |
| 28 |
HnRNP A1/A2 and SF2/ASF Regulate Alternative Splicing of Interferon Regulatory Factor-3 and Affect Immunomodulatory Functions in Human Non-Small Cell Lung Cancer Cells
Rong Guo, Yong Li, Jinying Ning et al. · PLoS ONE
Open access |
29 Apr 2013 |
56 |
| 29 |
Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients
Mengmeng Yang, Baoen Shan, Qiaoxia Li et al. · International Journal of Cancer
|
5 Sep 2012 |
53 |
| 30 |
Stimulation of alpha 7 nicotinic acetylcholine receptor (α7nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells
Marcus A. Ulleryd, Filip Mjörnstedt, Dimitra Panagaki et al. · Atherosclerosis
|
15 Jun 2019 |
44 |
| 31 |
Fragment-Based Identification of Amides Derived from trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)
Anthony M. Giannetti et al. · Journal of Medicinal Chemistry
Open access |
9 Jan 2014 |
42 |
| 32 |
Quinolones as HCV NS5B polymerase inhibitors
Dange V. Kumar, Roopa Rai, Ken A. Brameld et al. · Bioorganic & Medicinal Chemistry Letters
|
22 Nov 2010 |
40 |
| 33 |
The Proteome of Normal Pancreatic Juice
Courtney J. Doyle, Kyle W. Yancey, Henry Anthony Pitt et al. · Pancreas
Open access |
Dec 2011 |
38 |
| 34 |
Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification
Ting Liu, Jianan Rao, Wenting Hu et al. · Nature Communications
Open access |
28 Mar 2022 |
36 |
| 35 |
The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose
Gao Sun, Charles V. Jackson, Karen M. Zimmerman et al. · BMC Gastroenterology
Open access |
18 Mar 2019 |
36 |
| 36 |
Mature B Cells Are Critical to T-cell-mediated Tumor Immunity Induced by an Agonist Anti-GITR Monoclonal Antibody
Pengfei Zhou, Junzhuan Qiu, Lawrence L’Italien et al. · Journal of Immunotherapy
|
14 Sep 2010 |
35 |
| 37 |
Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population
Qiang Zhao, Xue Jia, Baoan Hong et al. · Cancer Cell International
Open access |
22 Sep 2020 |
34 |
| 38 |
Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Xuefei Yan, Beibei Tang, Biao Chen et al. · eLife
Open access |
11 Mar 2019 |
34 |
| 39 |
Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys
Yong‐Fu Xiao, Bingdi Wang, Xiaoli Wang et al. · BMC Anesthesiology
Open access |
20 Oct 2013 |
33 |
| 40 |
Pharmacokinetic Optimization of Class-Selective Histone Deacetylase Inhibitors and Identification of Associated Candidate Predictive Biomarkers of Hepatocellular Carcinoma Tumor Response
Jason Wong et al. · Journal of Medicinal Chemistry
Open access |
12 Oct 2012 |
31 |
| 41 |
Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes
Sung Hwan Lee et al. · Hepatology
Open access |
29 Mar 2022 |
29 |
| 42 |
Occurrence of ochratoxin A in wine and beer samples from China
Jianwei Wu, Yinfeng Tan, Yuqi Wang et al. · Food Additives and Contaminants Part B
|
11 Dec 2010 |
29 |
| 43 |
Humanized Mouse Models for Immuno‐oncology Drug Discovery
Rajendra Kumari, Gerold Feuer, Ludovic Bourré · Current Protocols
Open access |
Aug 2023 |
28 |
| 44 |
Molecular Characteristics of CTA056, a Novel Interleukin-2-Inducible T-Cell Kinase Inhibitor that Selectively Targets Malignant T Cells and Modulates Oncomirs
Wenchang Guo, Ruiwu Liu, Yoko Ono et al. · Molecular Pharmacology
Open access |
17 Aug 2012 |
28 |
| 45 |
Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models
Binchen Mao, Sheng Jie Guo · Cancer Research Communications
Open access |
13 Oct 2023 |
27 |
| 46 |
Effects of a purified krill oil phospholipid rich in long-chain omega-3 fatty acids on cardiovascular disease risk factors in non-human primates with naturally occurring diabetes type-2 and dyslipidemia
Petter‐Arnt Hals, Xiaoli Wang, Yong‐Fu Xiao · Lipids in Health and Disease
Open access |
17 Jan 2017 |
27 |
| 47 |
Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
Hua Jiang, Bo Song, Peng Wang et al. · Protein & Cell
Open access |
19 Sep 2017 |
26 |
| 48 |
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Peter S. Dragovich et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
21 Dec 2013 |
26 |
| 49 |
Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetes
Haihua Gu, Yongqiang Liu, Shuang Mei et al. · BMC Cardiovascular Disorders
Open access |
30 Oct 2015 |
26 |
| 50 |
A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology
Xiaoxi Xu et al. · PLoS ONE
Open access |
5 Jan 2023 |
24 |